UK markets close in 4 hours 37 minutes
  • FTSE 100

    7,321.35
    +89.07 (+1.23%)
     
  • FTSE 250

    23,184.70
    +303.37 (+1.33%)
     
  • AIM

    1,192.23
    +12.20 (+1.03%)
     
  • GBP/EUR

    1.1767
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.3247
    -0.0013 (-0.10%)
     
  • BTC-GBP

    38,832.90
    +2,137.00 (+5.82%)
     
  • CMC Crypto 200

    1,331.38
    +71.22 (+5.65%)
     
  • S&P 500

    4,591.67
    +53.24 (+1.17%)
     
  • DOW

    35,227.03
    +646.95 (+1.87%)
     
  • CRUDE OIL

    71.68
    +2.19 (+3.15%)
     
  • GOLD FUTURES

    1,782.50
    +3.00 (+0.17%)
     
  • NIKKEI 225

    28,455.60
    +528.23 (+1.89%)
     
  • HANG SENG

    23,983.66
    +634.28 (+2.72%)
     
  • DAX

    15,713.76
    +332.97 (+2.16%)
     
  • CAC 40

    7,025.11
    +159.33 (+2.32%)
     

Are Chamath Palihapitiya's SPACs IPOD and IPOF Worth Buying Now?

·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Out of the six SPACs Chamath Palihapitiya has launched so far, there are two that have yet to identify their acquisition targets. In this Fool Live video clip, recorded on March 15, Fool.com contributors Matt Frankel, CFP, Brian Withers, and Dan Caplinger discuss whether these two blank-check companies might be worth a look now.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting